Shares of Resverlogix Corp. (TSE:RVX – Get Free Report) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$0.10 and traded as high as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 117,000 shares.
Resverlogix Stock Performance
The company has a market capitalization of C$31.70 million, a PE ratio of -5.00 and a beta of 0.41. The company has a current ratio of 0.03, a quick ratio of 0.04 and a debt-to-equity ratio of -83.11. The firm’s 50-day simple moving average is C$0.10 and its 200-day simple moving average is C$0.10.
Resverlogix (TSE:RVX – Get Free Report) last issued its earnings results on Friday, May 15th. The biotechnology company reported C$0.01 EPS for the quarter. On average, research analysts predict that Resverlogix Corp. will post -0.22 earnings per share for the current year.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Read More
- Five stocks we like better than Resverlogix
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
